🔗 Share this article

An underground economy for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.

Investigational Treatment Acquiring Traction Via Social Media

Retatrutide, which remains in research studies, is being promoted by online personalities for its supposed weight-reducing properties. Viewers are encouraged to contact these accounts privately for source information, while also obtaining discount codes.

Active Trade on Messaging Platforms

Separately, a flourishing trade exists on messaging services, where communities with thousands of participants share “before and after” images, administration instructions and claims of rapid UK delivery. Sellers promote the substance there before directing buyers to WhatsApp for transactions.

Learning About Retatrutide

This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and glucagon. Early trials suggest it could assist individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Professionals Express Concerns

However, physicians and pharmacists have warned that the distribution of what remains an unlicensed medication in the United Kingdom is a cause for concern and could result in users injecting substances of uncertain source.

Some experts said the demand for retatrutide could be connected to the rising cost of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Implementation

Marketing the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that cannot be promoted or distributed for personal consumption under the British medical regulations.

Some influencers attempt to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still breach pharmaceutical, advertising, and consumer laws, potentially leading to fines, legal action or prison.

Platform Response and Content Removal

According to TikTok, the platform has taken down violative material and prohibited associated hashtags and search suggestions. The company stated it was dedicated to maintaining the service secure and investing in enhancing compliance measures.

Digital Marketplace Activities

Research also found communities with up to nine thousand participants selling the experimental drug using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” immediately displays channels with thousands of members, filled with photos of weight loss, glowing reviews and step-by-step instructions for mixing or administering at home.

Within minutes of entering one group, a vendor shared contact information, where the majority of purchases occur. The vendor provided an instruction manual and promised shipping within 48 hours. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one inquired about weight, medical conditions or previous experience.

Item Details and Pricing

Inside these communities, posts display black plastic parcels with postal service labels, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with sterile water, or ready-to-use injectors usually sold at 160 pounds for 20mg. When questioned how much time a injector should last, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A representative for Telegram said it regularly moderated dangerous material on its platform including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting substances they cannot confirm. Although the research behind this drug is sound, these digital products may not include what they claim,” stated Jason Murphy, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to recent price rises for approved slimming drugs such as Mounjaro. “With prices increasing, patients are using social media. But fake injections are highly dangerous. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she said.

Her staff has already encountered individuals harmed by personal administration from unconfirmed sources. “We understand the frustration, but buying from Telegram or WhatsApp is gambling with your well-being,” stated the doctor. “These materials could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a Lilly experimental substance not yet approved … may subject users to possibly significant medical dangers”.